Prognostic value of the CHAM score in non-small cell lung cancer patients treated with nivolumab

Clinical & Translational Oncology 2026

View at publisher
Authors: Ahmet Burak Ağaoğlu, Ferhat Ekinci, Mustafa Şahbazlar, Atike Pınar Erdoğan
DOI: 10.1007/s12094-026-04421-6
Cited by: 1
References: 30

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Inflammatory Biomarkers in Disease Prognosis Lung Cancer Research Studies

Publication details

Journal / source
Clinical & Translational Oncology
Publisher
Springer Science and Business Media LLC
Publication date
11 June 2026
Language
EN